CEL Press Articles
Business Wire - CEL-SCI Corporation to Raise $5.76 Million in Registered Direct Offering
Posted by admin / Under CELJanuary 26, 2012 --
VIENNA, Va. -- CEL-SCI Corporation (NYSE AMEX: CVM), a late-stage oncology company,ÃÂ has entered into definitive...
Market Wire - Boost in Biotech Funding Benefits CEL-SCI and Human Genome Sciences
Posted by admin / Under CELJanuary 25, 2012 --
The biotechnology industry has performed well in the early stages of 2012. The iShares NASDAQ Biotechnology Index is presently up nearly eight...
Market Wire - Ortronics Brings Thermal Management to Cisco Live London
Posted by admin / Under CELJanuary 20, 2012 --
Ortronics , a Group brand Legrand, the global leader in high performance network infrastructure solutions, will be a Gold Sponsor of Cisco...
Business Wire - CEL-SCI Corporation Releases Letter to Shareholders
Posted by admin / Under CELJanuary 20, 2012 --
VIENNA, Va. -- The following letter is being released by CEL-SCI Corporation (NYSE AMEX: CVM) to its shareholders:...
Market Wire - Wyse Reaffirms Cisco Collaboration With Superior Portfolio of Comprehensive Cloud Client Computing Solutions at Cisco Live 2012 in London, UK
Posted by admin / Under CELJanuary 1, 2012 --
Wyse Technology, the global leader in cloud client computing , is participating in Cisco Live 2012 , Cisco's flagship annual technical...
Market Wire - RepliCel Provides Quarterly Update on First-In-Man Clinical Trials
Posted by admin / Under CELJanuary 1, 2012 --
RepliCel Life Sciences Inc. (the "Company" or "RepliCel") (OTCBB:REPCF) is pleased to report that the six-month post injection follow-up period...
Market Wire - RepliCel to Present at the 4th Annual LD MICRO Growth Conference in Los Angeles, California
Posted by admin / Under CELDecember 1, 2011 --
RepliCel Life Sciences Inc. (the "Company" or "RepliCel") (OTCBB:REPCF) is pleased to report that David Hall, CEO will be presenting at the LD...
Business Wire - CEL- SCI Corporation Updates Phase III Clinical Activities for Investigational Cancer Therapy Multikine (Leukocyte Interleukin, Injection)
Posted by admin / Under CELDecember 1, 2011 --
VIENNA, Va. -- CEL-SCI Corporation (NYSE AMEX: CVM) provided an update today of the progress of its Phase III clinical...
